Cargando…
1416. The Economic Burden of Adverse Events Requiring Acute Care Services from Outpatient Parenteral Antibiotic Therapy (OPAT) Treatment
BACKGROUND: Antimicrobial resistance (AMR) is a growing threat. ESBL-producing Enterobacterales infections are rising, especially within the community setting. Patients requiring OPAT services will increase based on AMR to oral antibiotic (ABX) options. OPAT adverse events (AEs) are linked to the us...
Autores principales: | Rodriguez, Mauricio, Buscaglia, Georgia, Tolle, Steven, Michael, Darren |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9981867/ http://dx.doi.org/10.1093/ofid/ofac492.1245 |
Ejemplares similares
-
Outpatient parenteral antibiotic therapy (OPAT) for the management of bronchiectasis
por: Tu, Jacky, et al.
Publicado: (2023) -
OPAT: outpatient parenteral antimicrobial therapy
Publicado: (2020) -
A broader view on outpatient parenteral antibiotic therapy (OPAT) stewardship
por: Hess, Danielle, et al.
Publicado: (2022) -
Risk factors for failure of outpatient parenteral antibiotic therapy (OPAT) in infective endocarditis
por: Duncan, Christopher J. A., et al.
Publicado: (2013) -
760 Piperacillin/Tazobactam-Induced Adverse Drug Events in Pediatric Patients on Outpatient Parenteral Antimicrobial Therapy (OPAT)
por: Yusef, Dawood, et al.
Publicado: (2014)